Prostatitis, a prevalent urinary tract disorder in males, has a complex etiology that leads to
severe clinical discomfort. Pule'an Tablets, a classic single-component formulation primarily …

Introduction Although sertraline has been widely used for chronic prostatitis (CP), the
mechanisms are unclear. Herein, we explored the mechanisms of sertraline in treating CP …

In the past two decades, thousands of documents in the field of prostatitis have been
published. This bibliometric analysis aimed to assess the characteristics, hotspots and …

Background Chronic non-bacterial prostatitis (CNBP) accounts for more than 90% of clinical
prostatitis cases, and there is no specific and effective treatment for CNBP. The regulatory …

Chronic prostatitis (CP) is a common inflammatory condition of the prostate that is estimated
to effect 2%–10% of the world's male population. It can manifest as perineal, suprapubic, or …

Chronic primary pelvic pain syndrome (CPPPS) is a heterogeneous disease with unknown
pathogenesis and a lack of distinct pathological features, which complicates diagnosis and …

Background Despite widespread occurrence and poor comprehension, prostatitis has been
largely under‐researched. Objective To compare complaints, general and sexual health, co …

This paper aims to explain the key points and highlight some of the controversies in the
development of the British Pain Society's pelvic pain patient pathway map. Many clinicians …

Purpose The clinical term “prostatitis” refers to a clinical syndrome defined by the following 4
distinct entities: acute bacterial prostatitis (category 1), chronic bacterial prostatitis (category …

According to the internationally accepted National Institutes of Health (NIH) classification,
there are four prostatitis syndromes (1). Category I is acute bacterial prostatitis that presents …